diabetes glp 1 drugs Indications for GLP-1/GIP RA Summary Sheet and Beyond! Diabetes Patients Also Struggle to

NAD+ / NMN Increases cellular energy, provides anti-aging benefits, and supports longevity

"Most side effects of GLP-1 and GLP-1/GIP RAs involve gastrointestinal symptoms, are mild-to-moderate, and improve with time." - Maria D

To view or add a comment, sign in Every Mechanism Has a Safety Story The more I study LDL-lowering drugs, the more I realize each one has its own safety story

Rossing, F.M.M

however, gastrointestinal adverse effects such as nausea, vomiting, and diarrhea are the most frequently reported, particularly during the initial treatment phase ( Additionally, weight loss with GLP-1 RAs is accompanied by reductions in lean mass, with skeletal muscle accounting for approximately 15%40% of total weight loss ( 6 Conclusion and future directions The data strongly supports that SLD, is fueled by common pathways of altered metabolism and chronic inflammation, which are the central precipitating factors for HCC development across MASLD, ALD, and to some extent, chronic viral etiologies

[12] [13] However, it's important to note that FAERS data cannot establish incidence rates or causality due to voluntary reporting, potential reporting bias, and lack of denominator data